Deepak Chemtex FY26 profit falls 32% on lower revenue
Deepak Chemtex Limited reported a 32.4% decline in consolidated net profit to ₹846.88 lakh for the financial year ended March 31, 2026. Revenue from operations dropped 14.9% to ₹6,763.87 lakh, while total income decreased to ₹7,062.88 lakh. The Board of Directors approved the audited financial results on May 29, 2026. Statutory auditors Mittal & Associates issued an unmodified opinion on the results.

*this image is generated using AI for illustrative purposes only.
Deepak Chemtex Limited reported a 32.4% decline in consolidated net profit to ₹846.88 lakh for the financial year ended March 31, 2026, compared to ₹1,250.92 lakh in the previous year. Revenue from operations dropped 14.9% to ₹6,763.87 lakh from ₹7,944.51 lakh in FY25, while total income decreased to ₹7,062.88 lakh. The company's Board of Directors approved the audited standalone and consolidated financial results for the half and full year at a meeting held on May 29, 2026.
Financial Performance
The decline in profitability was driven by reduced revenue and increased expenses. Total expenses for the year stood at ₹5,902.79 lakh, lower than the ₹6,523.12 lakh recorded in the previous year. Profit before tax for the year ended March 31, 2026, was ₹1,160.09 lakh, a decrease from ₹1,672.33 lakh in the prior year. The basic earnings per share (EPS) for the year fell to ₹7.80 from ₹11.69 in the corresponding period last year.
Consolidated Financial Results
| Particulars | Year Ended March 31, 2026 (₹ in lakhs) | Year Ended March 31, 2025 (₹ in lakhs) |
|---|---|---|
| Revenue from Operations | 6,763.87 | 7,944.51 |
| Total Income | 7,062.88 | 8,195.37 |
| Total Expenses | 5,902.79 | 6,523.04 |
| Profit Before Tax | 1,160.09 | 1,672.33 |
| Net Profit | 846.88 | 1,250.92 |
Standalone Financial Results
On a standalone basis, the company reported a net profit of ₹659.26 lakh for FY26, down from ₹1,006.95 lakh in the previous year. Revenue from operations for the standalone entity decreased to ₹5,349.61 lakh from ₹6,799.68 lakh. Total expenses for the period were ₹4,755.61 lakh compared to ₹5,673.66 lakh in FY25.
Balance Sheet and Cash Flow
The company's consolidated total assets as of March 31, 2026, stood at ₹7,454.70 lakh, up from ₹6,711.96 lakh in the previous year. Shareholders' equity increased to ₹6,376.11 lakh, driven by reserves and surplus of ₹5,256.11 lakh. Cash and cash equivalents decreased to ₹401.94 lakh from ₹563.64 lakh at the end of the previous year.
Auditor's Report
Statutory auditors Mittal & Associates issued an audit report with an unmodified opinion for the half and financial year ended March 31, 2026. The auditors confirmed that the financial results present a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Accounting Standards. The audit was conducted in accordance with the Standards on Auditing specified under section 143(10) of the Companies Act, 2013.
Historical Stock Returns for Deepak Chemtex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.01% | -2.46% | -11.71% | -27.78% | -47.30% | -51.13% |
What strategic initiatives will Deepak Chemtex implement to reverse the decline in revenue and profitability for the upcoming fiscal year?
How will the reduction in cash and cash equivalents impact the company's ability to fund operations or invest in growth opportunities?
Are there specific market segments or product lines responsible for the revenue drop, and does the company plan to pivot its focus?



























